BRCA1 a BRCA2 mutace u žen s familiárním nebo časným výskytem nádorů prsu/ovária v České republice

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209805%3A_____%2F04%3A00012673" target="_blank" >RIV/00209805:_____/04:00012673 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

BRCA1 and BRCA2 mutations in women with familial or early-onset breast/ovarian cancer in the Czech Republic

Popis výsledku v původním jazyce

Germline mutations in BRCA1 and BRCA2 genes account for majority of hereditary breast and ovarian cancer. The complete coding sequence analysis of both genes was carried out in 197 breast/ovarian cancer patients from high-risk families and 53 patients with sporadic breast/ovarian cancer. In summary, 59 mutations (16 different) in BRCA1 gene and 29 mutations (17 different) in BRCA2 gene were identified in unrelated breast and/or ovarian index cases. The most frequently found mutations in BRCA1 gene werec.5385dupC (22 cases), c.3819-_3823delGTAAA (8 cases) and c.300T&amp;#61502;G (6 cases). The most frequently found mutations in BRCA2 gene were c.8138_8142delCCTTT (7 cases) and c.8765_8766delAG (7 cases). Altogether, these 5 mutations represented 56,8%of all detected mutations. A broad spectrum of other mutations was detected including four novel mutations (c.2881delA in BRCA1 gene; and c. 6677_6678delAA, c.6982dupT and c.8397_8400dupTGGG in BRCA2 gene). Deleterious mutations were foun

Název v anglickém jazyce

BRCA1 and BRCA2 mutations in women with familial or early-onset breast/ovarian cancer in the Czech Republic

Popis výsledku anglicky

Germline mutations in BRCA1 and BRCA2 genes account for majority of hereditary breast and ovarian cancer. The complete coding sequence analysis of both genes was carried out in 197 breast/ovarian cancer patients from high-risk families and 53 patients with sporadic breast/ovarian cancer. In summary, 59 mutations (16 different) in BRCA1 gene and 29 mutations (17 different) in BRCA2 gene were identified in unrelated breast and/or ovarian index cases. The most frequently found mutations in BRCA1 gene werec.5385dupC (22 cases), c.3819-_3823delGTAAA (8 cases) and c.300T&amp;#61502;G (6 cases). The most frequently found mutations in BRCA2 gene were c.8138_8142delCCTTT (7 cases) and c.8765_8766delAG (7 cases). Altogether, these 5 mutations represented 56,8%of all detected mutations. A broad spectrum of other mutations was detected including four novel mutations (c.2881delA in BRCA1 gene; and c. 6677_6678delAA, c.6982dupT and c.8397_8400dupTGGG in BRCA2 gene). Deleterious mutations were foun

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FD - Onkologie a hematologie

OECD FORD obor

—

Projekt

Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>Z - Vyzkumny zamer (s odkazem do CEZ)

Rok uplatnění

2004

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Human mutation

ISSN

1059-7794

e-ISSN

—

Svazek periodika

23

Číslo periodika v rámci svazku

4

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

2

Strana od-do

397-398

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—